These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 5650322
1. Effect of antiarrhythmic agents on cardiac metabolism. Belliveau RE, Covino BG. Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):130-8. PubMed ID: 5650322 [No Abstract] [Full Text] [Related]
3. Metabolic effects of bunaftine, a new antiarrhythmic agent: comparison with quinidine, ajmaline, procainamide, xylocaine and propranolol. Castellucci A. Arzneimittelforschung; 1976 Feb; 26(2):241-4. PubMed ID: 947206 [Abstract] [Full Text] [Related]
4. The effect of buthobendin on glycolysis in rabbit myocardial slices in vitro. Marchut E, Gumińska M, Kedryna T. Pol J Pharmacol Pharm; 1988 Feb; 40(2):167-72. PubMed ID: 3237566 [Abstract] [Full Text] [Related]
5. Effects of interaction of antiarrhythmic drugs and beta-blocking agents on the isolated rabbit heart. Bertaccini G, Impicciatore M, Visioli O, Malagnino G. Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):209-17. PubMed ID: 5709785 [No Abstract] [Full Text] [Related]
6. A comparison of the cardiac activity of a new antiarrhythmic drug--pipazetate--with quinidine, procainamide, antazoline and diphenylhydantoin. Giuliano H. Arch Int Pharmacodyn Ther; 1970 Nov; 188(1):189-99. PubMed ID: 4394965 [No Abstract] [Full Text] [Related]
7. Actions of some antiarrhythmic agents on heart sarcolemma. Dhalla NS, Harrow JA, Anand MB. Biochem Pharmacol; 1978 Nov; 27(8):1281-3. PubMed ID: 151545 [No Abstract] [Full Text] [Related]
8. Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs. Singh BN. Angiology; 1978 Mar; 29(3):206-42. PubMed ID: 347988 [No Abstract] [Full Text] [Related]
9. [Relationship between the chemical structure and antiarrhythmic effect in a series of 10-acyl derivatives of 2-trifluoro substituted phenothiazines and esters of phenothiazine 2-carbamic acids]. Vikhliaev IuI, Kaverina NV, Senova ZP, Ul'ianova OV. Farmakol Toksikol; 1971 Mar; 34(2):163-7. PubMed ID: 5563385 [No Abstract] [Full Text] [Related]
10. Binding of antiarrhythmic drugs to human placenta in vitro. Bailey DN. Ann Clin Lab Sci; 1999 Mar; 29(3):209-12. PubMed ID: 10440585 [Abstract] [Full Text] [Related]
12. Anti-fibrillary and anti-adrenaline activity of beta-receptor blocking drugs. Raper C, Jowett A. Eur J Pharmacol; 1967 Sep; 1(5):353-62. PubMed ID: 4385120 [No Abstract] [Full Text] [Related]
13. The cardioactive and related properties of N-methyl-N-( -phenylethyl)-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-2-naphthylamine hydrochloride (2-AT-1). Graeff DM, Johnson WE, Martin AR. Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):134-48. PubMed ID: 4398737 [No Abstract] [Full Text] [Related]
15. Studies on the combined use of beta-adrenergic blockade and antiarrhythmic drugs. Mazurowa A, Szadowska A, Szmigielski A, Litwinowicz A. Arch Immunol Ther Exp (Warsz); 1970 Sep; 18(2):280-7. PubMed ID: 4393014 [No Abstract] [Full Text] [Related]
16. Inhibition of incorporation of leucine into myocardial proteins of the rat by antiarrhythmic agents. Beller BM, Mongillo S. Circ Res; 1969 Oct; 25(4):401-6. PubMed ID: 5347221 [No Abstract] [Full Text] [Related]
17. [The interaction of antiarrhythmic drugs with other drugs]. Yamaguchi I. Kokyu To Junkan; 1985 Aug; 33(8):956-69. PubMed ID: 2866571 [No Abstract] [Full Text] [Related]